Hepatitis C: standard of treatment and what to do for global elimination
L Di Marco, C La Mantia, V Di Marco - Viruses, 2022 - mdpi.com
Hepatitis C virus infection has a substantial effect on morbidity and mortality worldwide
because it is a cause of cirrhosis, hepatocellular carcinoma, liver transplantation, and liver …
because it is a cause of cirrhosis, hepatocellular carcinoma, liver transplantation, and liver …
Securing wider EU commitment to the elimination of hepatitis C virus
H Wedemeyer, TL Tergast, JV Lazarus… - Liver …, 2023 - Wiley Online Library
In 2016, the Hepatitis B and C Public Policy Association (HepBCPPA), gathered all the main
stakeholders in the field of hepatitis C virus (HCV) to launch the now landmark HCV …
stakeholders in the field of hepatitis C virus (HCV) to launch the now landmark HCV …
[HTML][HTML] Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation
LA Kondili, A Aghemo, M Andreoni, M Galli… - Digestive and Liver …, 2022 - Elsevier
Although Italy has been on track for Hepatitis C Virus (HCV) elimination since 2019, it fell off
track due to the decrease in the number of treated patients. HCV elimination in Italy will be …
track due to the decrease in the number of treated patients. HCV elimination in Italy will be …
[HTML][HTML] Estimated prevalence of undiagnosed HCV infected individuals in Italy: a mathematical model by route of transmission and fibrosis progression
LA Kondili, M Andreoni, A Alberti, S Lobello… - Epidemics, 2021 - Elsevier
Background The universal treatment of diagnosed patients with chronic HCV infection has
been widely conducted in Italy since 2017. However, the pool of individuals diagnosed but …
been widely conducted in Italy since 2017. However, the pool of individuals diagnosed but …
Elimination of hepatitis C in southern Italy: A model of HCV screening and linkage to care among hospitalized patients at different hospital divisions
Background: Free-of-charge HCV screening in some key populations and in 1969–1989
birth cohorts has been funded in Italy as the first step to diagnosing individuals who are …
birth cohorts has been funded in Italy as the first step to diagnosing individuals who are …
From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy
Italy has had the highest prevalence of hepatitis C virus (HCV) infection and mortality from
HCV-related liver cancer in Europe. Although direct-acting antivirals (DAA) were initially …
HCV-related liver cancer in Europe. Although direct-acting antivirals (DAA) were initially …
Implementation of HCV screening in the 1969–1989 birth‐cohort undergoing COVID‐19 vaccination
R D'Ambrosio, G Rizzardini, M Puoti… - Liver …, 2022 - Wiley Online Library
Abstract Background and Aim The World Health Organization (WHO) goal of hepatitis C
virus (HCV) elimination by 2030 relies on the scaling‐up of both identification and linkage to …
virus (HCV) elimination by 2030 relies on the scaling‐up of both identification and linkage to …
The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four European countries
FS Mennini, A Marcellusi, S Robbins Scott… - Liver …, 2021 - Wiley Online Library
Abstract Background and Aims We assessed the clinical and economic impact of direct‐
acting antiviral (DAA) therapy for hepatitis C virus (HCV) in England, Italy, Romania and …
acting antiviral (DAA) therapy for hepatitis C virus (HCV) in England, Italy, Romania and …
Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements
Abstract The World Health Organization (WHO) targets for eliminating HCV by 2030 may be
overambitious for many high‐income countries. Recent analyses (ie, data from 2017 to …
overambitious for many high‐income countries. Recent analyses (ie, data from 2017 to …
[HTML][HTML] Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years
Hepatitis C is a disease for which in approximately 30 years we have gone from the
discovery of the causative agent in 1989, to the introduction of direct-acting antiviral (DAAs) …
discovery of the causative agent in 1989, to the introduction of direct-acting antiviral (DAAs) …